creating a
healthier future
Catarina Leite Pereira
Representative

Catarina got her PhD in Biomedical Sciences (ICBAS/UP) in 2017 and is currently an Associate Researcher at the Nanomedicine at the Translational Drug Delivery Group, Instituto de Investigação e Inovação em Saúde (I3S), were she leads a team on advanced modelling of musculoskeletal pediatric tumors. Currently she coordinates two projects on the development of a bioengineered 3D model of osteosarcoma, aiming at providing a tool to unravel tumor development, the metastatic process and to screen in a biologically relevant setting novel therapies and targeted nanomedicines. 

Catarina has been working in the biomedical engineering field for 15 years, being involved in multiple projects in the area of nanotechnology, immunomodulation, musculoskeletal disorders and disease in vitro modelling. She has participated in 10 international and national projects during her career (DISC REGENERATION, RESTORE, GENEGUT, DUO-DIO, EUROSPINE, among others). She has vast national/international network of collaborators from academia (i3S (other research groups), University of Oulu, Shanghai Jiao Tong University School of Medicine, and industry (FINNADVANCE, React4Life). Through her scientific path, Catarina has published 40 articles, displaying a h-index of 20 (source: scopus). She has participated in multiple dissemination actions (>30 participations) both in national and international conferences, building up her reputation and recognition by her peers, as can be perceived by the high number of citations (>800) and invitations to act as an expert panel reviewer for international funding agencies, examiner, lecturer, invited speaker and integration of scientific and PhD Advisory committees. Catarina has supervised 4 trainees (BSc), 3 master students (one ongoing) and is currently supervising 3 PhD students. Her responsibility towards the scientific endeavor has not been restricted to research, she actively participates in public awareness actions for science dissemination in primary and secondary schools and exhibitions to general population. 

Catarina has contributed to secure funding of the Liga Portuguesa Contra o Cancro (15K euros) and FCT (50k euros) as Principal Investigator (PI), from Gilead Genese Program (35K euros) as co-PI and from the European Commission (H2020 RESTORE (5.4M Euros) and HORIZON-HLTH-2021-TOOL-06 GENEGUT (4.9M Euros) as a team member. Catarina has been recently elected SPLC-CRS Board Director (2024-2026) and is the vice-chair of the Nanotechnologies for Regenerative Medicine Working group of ETPN (European Technology Platform of Nanomedicines).

ONGOING Projects :

  • MICKEY (50k€) – RESTART FCT (2023-2025)
  • B2Tek-4OS (15k€) - Liga Portuguesa Contra o Cantro – Bolsas em Sarcomas Pediatricos Nôno

 

Research Team:

  • Mª Francisca Corte-Real, MSc student (Master in Bioemedical Eng - FEUP)
  • Ana Duarte, MSc student (Master in Biotech and Pharma -University of Coimbra (2024-)
  • Carolina Vieira, Research Assistant (2024-)
  • Sofia Costa, PhD Fellow  (2024-) UPorto/UMacau
  • Sofia Dias (2021-2025), FCT PhD Fellow, MSc – PhD Candidate, PhD in Biomedical Sciences ICBAS/UP
  • Diogo Horta (2020-2024), FCT PhD Fellow – PhD Candidate, PhD in Neurosciences FMUP

 

Alumni Team members:

  • Carolina Vieira, Research trainee (2024), Integrated Master in Bioengineering, ICBAS/FEUP
  • Sofia Costa (2022-2023), Master in Biotechnology Applications and Synthetic biology, FCUP
  • João Rodrigues (2020-2021), Integrated Master in Bioengineering, ICBAS/FEUP
  • Rui Almeida: (2017-2018), Integrated Master in Bioengineering, ICBAS/FEUP (Grade 18)
  • Renata Basto, Research trainee (2018), Integrated Master in Bioengineering, ICBAS/FEUP
  • Maria Leonor Correia (2018), Integrated Master in Bioengineering, ICBAS/FEUP
  • Rui Almeida (2017) Integrated Master in Bioengineering, ICBAS/FEUP

Selected Publications

Costa S., Rodrigues J., Vieira C., Dias S., Viegas J., Castro F., Sarmento B., Leite Pereira C.
Advancing osteosarcoma 3D modeling in vitro for novel tumor microenvironment-targeted therapies development. Journal of Controlled Release376:1068-1085, 2024. [Journal: Article] [IF: 10.5 (*)]
DOI: 10.1016/j.jconrel.2024.10.068 SCOPUS: 85208199433

Pereira Vasconcelos D., Leite Pereira C., Couto M., Neto E., Ribeiro B., Albuquerque F., Freitas A., Alves C.J., Klinkenberg G., McDonagh B.H., Schmid R.B., Seitz A.M., de Roy L., Ignatius A., Haaparanta A.M., Muhonen V., Sarmento B., Lamghari M.
Nanoenabled Immunomodulatory Scaffolds for Cartilage Tissue Engineering. Advanced Functional Materials34(29):, 2024. [Journal: Article] [CI: 1] [IF: 18.5 (*)]
DOI: 10.1002/adfm.202400627 SCOPUS: 85187945931

Viegas J., Costa S., Dias S., Pereira C.L., Sarmento B.
Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening. Advanced Science:, 2024. [Journal: Article] [IF: 14.3 (*)]
DOI: 10.1002/advs.202408707 SCOPUS: 85207629059

Ferreira B., Ferreira C., Martins C., Nunes R., das Neves J., Leite-Pereira C., Sarmento B.
Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease. Journal of Controlled Release377:675-688, 2025. [Journal: Article] [IF: 10.5 (*)]
DOI: 10.1016/j.jconrel.2024.11.070 SCOPUS: 85210380595

Couto M., Vasconcelos D.P., Pereira C.L., Neto E., Sarmento B., Lamghari M.
Neuro-Immunomodulatory Potential of Nanoenabled 4D Bioprinted Microtissue for Cartilage Tissue Engineering. Advanced Healthcare Materials:, 2024. [Journal: Article] [IF: 10 (*)]
DOI: 10.1002/adhm.202400496 SCOPUS: 85199140468

Jiang W., Hou F., Gu Y., Saiding Q., Bao P., Tang J., Wu L., Chen C., Shen C., Pereira C.L., Sarmento M., Sarmento B., Cui W., Chen L.
Local bone metabolism balance regulation via double-adhesive hydrogel for fixing orthopedic implants. Bioactive Materials12:169-184, 2022. [Journal: Article] [CI: 18] [IF: 18,9]
DOI: 10.1016/j.bioactmat.2021.10.017 SCOPUS: 85120688144

Neto E., Monteiro A.C., Leite Pereira C., Simões M., Conde J.P., Chu V., Sarmento B., Lamghari M.
Micropathological Chip Modeling the Neurovascular Unit Response to Inflammatory Bone Condition. Advanced Healthcare Materials11(11):, 2022. [Journal: Article] [CI: 20] [IF: 10]
DOI: 10.1002/adhm.202102305 SCOPUS: 85125234828

Castro F., Leite Pereira C., Helena Macedo M., Almeida A., José Silveira M., Dias S., Patrícia Cardoso A., José Oliveira M., Sarmento B.
Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening. Advanced Drug Delivery Reviews175:, 2021. [Journal: Review] [CI: 37] [IF: 17,9]
DOI: 10.1016/j.addr.2021.06.001 SCOPUS: 85108070633

Castro F., Pinto M.L., Pereira C.L., Serre K., Barbosa M.A., Vermaelen K., Gärtner F., Gonçalves R.M., De Wever O., Oliveira M.J.
Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. Biomaterials257:, 2020. [Journal: Article] [CI: 69] [IF: 12,5]
DOI: 10.1016/j.biomaterials.2020.120218 SCOPUS: 85088642097

Xu Y., Gu Y., Cai F., Xi K., Xin T., Tang J., Wu L., Wang Z., Wang F., Deng L., Pereira C.L., Sarmento B., Cui W., Chen L.
Metabolism Balance Regulation via Antagonist-Functionalized Injectable Microsphere for Nucleus Pulposus Regeneration. Advanced Functional Materials30(52):, 2020. [Journal: Article] [CI: 76] [IF: 18,8]
DOI: 10.1002/adfm.202006333 SCOPUS: 85091482692

Castro F., Pinto M.L., Almeida R., Pereira F., Silva A.M., Pereira C.L., Santos S.G., Barbosa M.A., Gonçalves R.M., Oliveira M.J.
Chitosan/poly(γ-glutamic acid) nanoparticles incorporating IFN-γ for immune response modulation in the context of colorectal cancer. Biomaterials Science7(8):3386-3403, 2019. [Journal: Article] [CI: 38] [IF: 6,2]
DOI: 10.1039/c9bm00393b SCOPUS: 85069760890

Teixeira J.H., Pereira C.L., Almeida M.I., Teixeira G.Q., Gonçalves R.M., Barbosa M.A., Santos S.G.
Articular Repair/Regeneration in Healthy and Inflammatory Conditions: From Advanced In Vitro to In Vivo Models. Advanced Functional Materials30(44):, 2020. [Journal: Review] [CI: 9] [IF: 18,8]
DOI: 10.1002/adfm.201909523 SCOPUS: 85081533594